Henrik Clausen Selected Research

Pancreatic Neoplasms (Pancreatic Cancer)

10/2021	MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated short O-glycans.
1/2021	Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancer.
9/2014	Immature truncated O-glycophenotype of cancer directly induces oncogenic features.
4/2013	Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.
1/2013	Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.
3/2008	Mucin-type O-glycosylation and its potential use in drug and vaccine development.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Henrik Clausen Research Topics

Disease

52	Neoplasms (Cancer) 07/2023 - 06/2003
13	Carcinoma (Carcinomatosis) 10/2020 - 06/2003
11	Breast Neoplasms (Breast Cancer) 01/2015 - 12/2002
9	Adenocarcinoma 11/2016 - 03/2008
6	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 03/2008
6	Neoplasm Metastasis (Metastasis) 01/2021 - 02/2010
5	Ovarian Neoplasms (Ovarian Cancer) 10/2020 - 05/2014
4	Infections 07/2023 - 09/2002
3	Carcinogenesis 10/2021 - 10/2004
3	Calcinosis 01/2020 - 07/2006
3	Hyperphosphatemia 01/2020 - 11/2011
3	Colorectal Neoplasms (Colorectal Cancer) 05/2016 - 04/2011
2	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2023 - 01/2019
2	Thrombocytopenia (Thrombopenia) 12/2021 - 08/2009
2	Congenital Disorders of Glycosylation 01/2018 - 02/2015
2	Stomach Neoplasms (Stomach Cancer) 06/2015 - 03/2013
2	IGA Glomerulonephritis (IGA Nephropathy) 11/2014 - 03/2013
2	Multiple Myeloma 05/2014 - 11/2006
2	Metaplasia 04/2013 - 01/2011
2	Disease Progression 04/2013 - 10/2010
2	Hyperostosis 12/2012 - 11/2011
2	Prostatic Neoplasms (Prostate Cancer) 02/2010 - 12/2007
1	Nervous System Diseases (Neurological Disorders) 03/2024
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2022
1	Influenza in Birds (Avian Flu) 01/2022
1	Arthritis (Polyarthritis) 01/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Leukemia 01/2022
1	Type 2 Diabetes Mellitus (MODY) 10/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021

Drug/Important Bio-Agent (IBA)

24	Polysaccharides (Glycans)IBA 01/2023 - 10/2004
20	MucinsIBA 01/2022 - 06/2003
17	Glycoproteins (Glycoprotein)IBA 01/2023 - 06/2005
17	AntigensIBA 01/2020 - 06/2003
14	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2002
13	EpitopesIBA 01/2022 - 06/2003
12	Biomarkers (Surrogate Marker)IBA 10/2020 - 02/2010
11	AntibodiesIBA 01/2023 - 10/2003
11	GlycopeptidesIBA 01/2020 - 02/2006
8	Mucin-1 (CA 15-3 Antigen)IBA 01/2016 - 10/2004
7	Peptides (Polypeptides)IBA 01/2020 - 06/2003
7	GlycosyltransferasesIBA 01/2018 - 06/2003
7	VaccinesIBA 11/2015 - 10/2003
6	CarbohydratesIBA 01/2020 - 06/2003
6	Monoclonal AntibodiesIBA 05/2014 - 05/2005
5	EnzymesIBA 01/2023 - 01/2011
5	LectinsIBA 10/2020 - 10/2009
5	Chimeric Antigen ReceptorsIBA 01/2020 - 01/2016
5	AutoantibodiesIBA 05/2014 - 02/2010
5	Polypeptide N-acetylgalactosaminyltransferaseIBA 06/2012 - 07/2006
4	Galactose (Galactopyranose)FDA LinkGeneric 10/2020 - 09/2007
4	Tumor Viral Antigens (Large T Antigen)IBA 01/2019 - 10/2009
4	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 12/2007 - 10/2003
3	SialyltransferasesIBA 01/2022 - 02/2006
3	Sialyl Lewis X AntigenIBA 01/2021 - 07/2012
3	Protein Isoforms (Isoforms)IBA 01/2021 - 03/2012
3	C-Type Lectins (C-Type Lectin)IBA 10/2020 - 09/2007
3	AcetylgalactosamineIBA 01/2020 - 04/2012
3	Tn antigenIBA 01/2020 - 01/2007
3	Surface Antigens (Surface Antigen)IBA 01/2020 - 10/2003
3	Tumor Biomarkers (Tumor Markers)IBA 11/2015 - 02/2015
3	DisaccharidesIBA 10/2009 - 05/2005
3	saponin QA-21V1 (QS21)IBA 12/2007 - 05/2005
2	Indicators and Reagents (Reagents)IBA 01/2022 - 08/2010
2	Gemcitabine FDA Link 10/2021 - 01/2021
2	SugarsIBA 10/2020 - 01/2020
2	Threonine (L-Threonine)FDA Link 01/2020 - 05/2005
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020 - 08/2013
2	Cadherins (E-Cadherin)IBA 01/2020 - 12/2013
2	Serine (L-Serine)FDA Link 01/2020 - 05/2005
2	AutoantigensIBA 01/2016 - 03/2008
2	Immunoglobulin A (IgA)IBA 11/2014 - 03/2013
2	Transcription Factors (Transcription Factor)IBA 12/2013 - 05/2012
2	CA-19-9 Antigen (CA 19-9 Antigen)IBA 04/2013 - 07/2012
2	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 04/2013 - 07/2012
2	sialosyl-Tn antigenIBA 01/2011 - 10/2004
2	MonosaccharidesIBA 12/2010 - 05/2005
2	GlycoconjugatesIBA 10/2009 - 10/2005
2	TransferasesIBA 01/2007 - 06/2003
2	SaponinsIBA 05/2005 - 10/2003
1	Proteoglycans (Proteoglycan)IBA 03/2024
1	Carisoprodol (Soma)FDA LinkGeneric 01/2023
1	Sialic AcidsIBA 01/2023
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2023
1	GlycosphingolipidsIBA 01/2023
1	sialic acid receptorIBA 01/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2022
1	monomethyl auristatin EIBA 01/2022
1	podocalyxinIBA 01/2022
1	Platelet Factor 4IBA 12/2021
1	Heparin (Liquaemin)FDA LinkGeneric 12/2021
1	AnticoagulantsIBA 12/2021
1	Insulin (Novolin)FDA Link 10/2021
1	NucleosidesIBA 10/2021
1	SelectinsIBA 01/2021

Therapy/Procedure

7	Therapeutics 07/2023 - 11/2006
4	Immunotherapy 04/2013 - 02/2006
3	Ligation 06/2015 - 07/2012
2	Enzyme Replacement Therapy 01/2023 - 01/2019